For those who snore regularly, whether due to anatomical factors, lifestyle choices, or health conditions, NiteHush Pro ...

Leading health technology, Resmed, has announced its home sleep apnea test, NightOwl, is now available across the United ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

Key Takeaways Night terrors are episodes of screaming, crying, or thrashing that usually occur two to three hours after ...

Three experts explain how obstructive sleep apnea, an often-ignored cardiovascular risk factor, may affect your heart and treatment options.

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. Patient monitoring companies within the ...

Dr. David Blaine and Dr. Justin Douglas, otolaryngologists at the Beckley ARH Hospital Ear, Nose and Throat Clinic, recently ...

NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...

Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...

Sleep apnea can have untold consequences even in your waking hours. The good news? The condition is treatable.